Drug Topics e-News:
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe. |
|
|
|
|
Newest: An update on Clostridium difficile infection
For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
Last month’s survey results:
Would you join a pharmacists' union?
Total: 866
* Absolutely not. 37%
* Some pharmacists might need one, but I wouldn't join. 17%
* I'm afraid to join, in case it jeopardizes my job. 7%
* Sign me up! 40%
|
|
This month we would like to know...
Approximately how much of your workday is spent dealing with insurance matters?
* 1/4 or less
* up to 1/3
* up to 1/2
* up to 2/3
* 3/4 or more
|
|
|
|
|
|
Drop FFS, Save $30 billion on Medicaid
State Medicaid programs could save $30 billion over the next decade by replacing fee for service pharmacy programs with managed care programs like those used in Medicare Part D, according to a new report on Medicaid pharmacy spending sponsored by the Pharmaceutical Care Management Association. Read full article. |
|
|
DT Blog
|
A discussion generated by Drug Topics’ readers, editorial staff, and advisory board
Kristin Thienemann, PharmD candidate
Brittany Ward, PharmD candidate
Kathleen Welch, PharmD candidate
Kenneth Willinger III, PharmD candidate |
Plan B: The debate continues
Read full article.
|
|
New 3-drug regimen improves outcomes for myeloma patients
The addition of bortezomib to the standard induction therapy before double autologous stem-cell transplantation for patients with multiple myeloma appears to improve nearly threefold the rates of complete or near-complete response, according to research published online in The Lancet, HealthDay News reported. Read full article.
|
|
|
|
Duloxetine found to reduce joint pain associated with breast cancer treatment
Duloxetine (Cymbalta, Eli Lilly), used to treated depression and anxiety, was found to be effective at reducing joint and muscle pain associated with breast cancer treatment. Read full article.
|
|
Increased reduction in LDL cholesterol lessens vascular events
Further reductions in LDL cholesterol through more intensive statin regimens safely produce definite further reductions in vascular events, even down to very low LDL levels, lower than current targets, according to the results of 2 meta-analyses, The Lancet reported. There was no evidence of any lower threshold where the benefit is not seen. Read full article.
|
|
|
|
|
|
New study concludes risk of pneumonia increases with H2 and PPI therapies
A study released by the Canadian Medical Association Journal reported that the use of acid-suppressive drugs could be linked to an increased risk of pneumonia. Read full article.
|
|
|
|
Meetings and events
February 6-8, 2011 NACDS Regional Chain Conference
Naples, FL
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-837-4300
February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611
March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
hecker@nacds.org
March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734
|
|
|
Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
